Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
60 hedge funds and large institutions have $37.2M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 12 closing their positions.
289% more call options, than puts
Call options by funds: $183K | Put options by funds: $47K
4% more capital invested
Capital invested by funds: $35.7M → $37.2M (+$1.52M)
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
14% less funds holding
Funds holding: 70 → 60 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.75M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.15M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$249K |
| 4 |
Goldman Sachs
New York
|
+$202K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$750K |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$645K |
| 3 |
D.E. Shaw & Co
New York
|
-$540K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$396K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$307K |
FRTX Hedge Fund Activity: Q3 2014 in Review
60 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2014, worth a combined $37.2M — up 4.3% from $35.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of FRTX and 2 opened new positions — a net loss of 10 holders — while 17 trimmed existing stakes and 16 added.
The largest buyer was RA Capital Management, opening a new position worth an estimated $6.75M. The largest seller was Northern Trust, cutting an estimated $750K.
- 60 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2014, down from 70 in Q2 2014.
- Funds reported $37.2M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2014, up 4.3% quarter-over-quarter.
- 2 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2014 and 12 closed out, a net change of -10 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2014 was RA Capital Management, an estimated $6.75M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2014 was Northern Trust, an estimated $750K sold.
Based on aggregated 13F filings for Q3 2014.